Table 1 Comorbidity among NTM cases in Florida from 2012 to 2018
Comorbidity | NTM (total number: 7963) (%) |
|---|---|
Smoking | 500 (6.3%) |
Non-smoking | 3306 (41.5%) |
Immunotherapy | 0 (0%) |
Immunocompromised | 4406 (55.3%) |
Steroid therapy > 3 months | 74 (0.99%) |
Alpha 1 antitrypsin | 37 (0.46%) |
Bronchiectasis | 2445 (30.7%) |
Crohn’s Disease | 102 (1.3%) |
COPD | 2207 (27.7%) |
Cystic Fibrosis | 329 (4.1%) |
Diabetes | 1980 (24.9%) |
GERD | 3374 (42.4%) |
HIV | 1281 (16.1%) |
Hyperlipidemia | 2993 (37.6%) |
Hypertension | 3494 (43.9%) |
Immunodeficiency | 918 (11.5%) |
Lung transplant recipient | 101 (1.3%) |
Neoplasm | 3497 (43.9%) |
Tuberculosis | 841 (10.6%) |
Ulcerative colitis | 108 (1.4%) |